Groupe la Francaise Takes Position in The Clorox Company $CLX

Groupe la Francaise acquired a new stake in The Clorox Company (NYSE:CLX) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 26,876 shares of the company’s stock, valued at approximately $3,213,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. American National Bank & Trust grew its stake in Clorox by 69.5% in the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after acquiring an additional 89 shares during the period. NewSquare Capital LLC lifted its holdings in shares of Clorox by 567.6% during the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock valued at $27,000 after purchasing an additional 193 shares in the last quarter. Hantz Financial Services Inc. bought a new position in shares of Clorox during the 2nd quarter valued at about $31,000. Ransom Advisory Ltd acquired a new position in shares of Clorox in the 1st quarter valued at approximately $35,000. Finally, MTM Investment Management LLC bought a new stake in Clorox during the 2nd quarter worth approximately $37,000. 78.53% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on CLX shares. Barclays cut their price target on shares of Clorox from $112.00 to $108.00 and set an “underweight” rating on the stock in a research note on Tuesday, November 4th. Wells Fargo & Company cut their price objective on shares of Clorox from $125.00 to $117.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 4th. Bank of America lowered their target price on Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a report on Wednesday, October 8th. Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a research note on Tuesday, October 14th. Finally, Morgan Stanley reduced their price objective on Clorox from $137.00 to $125.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 4th. One analyst has rated the stock with a Buy rating, thirteen have given a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat.com, Clorox currently has an average rating of “Reduce” and an average price target of $125.69.

Clorox Trading Down 0.7%

Shares of NYSE:CLX opened at $105.12 on Thursday. The company’s 50-day moving average price is $112.69 and its two-hundred day moving average price is $120.64. The Clorox Company has a one year low of $98.20 and a one year high of $171.37. The company has a debt-to-equity ratio of 18.01, a current ratio of 0.76 and a quick ratio of 0.50. The stock has a market capitalization of $12.82 billion, a PE ratio of 16.50, a price-to-earnings-growth ratio of 0.53 and a beta of 0.57.

Clorox (NYSE:CLX) last released its earnings results on Monday, November 3rd. The company reported $0.85 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter in the previous year, the business earned $1.86 earnings per share. Clorox’s quarterly revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, equities analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th will be paid a dividend of $1.24 per share. The ex-dividend date is Wednesday, January 28th. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.7%. Clorox’s dividend payout ratio is currently 77.86%.

Insider Activity at Clorox

In other news, Director Pierre R. Breber bought 4,000 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The stock was acquired at an average cost of $104.13 per share, with a total value of $416,520.00. Following the completion of the purchase, the director owned 13,000 shares of the company’s stock, valued at $1,353,690. This represents a 44.44% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.63% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.